<VariationArchive VariationID="1074440" VariationName="NM_006073.4(TRDN):c.423del (p.Glu142fs)" VariationType="Deletion" Accession="VCV001074440" Version="47" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2021-05-10" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1060571" VariationID="1074440">
      <GeneList>
        <Gene Symbol="TRDN" FullName="triadin" GeneID="10345" HGNC_ID="HGNC:12261" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q22.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="123216339" stop="123636950" display_start="123216339" display_stop="123636950" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="123537483" stop="123958237" display_start="123537483" display_stop="123958237" Strand="-" />
          </Location>
          <OMIM>603283</OMIM>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_006073.4(TRDN):c.423del (p.Glu142fs)</Name>
      <CanonicalSPDI>NC_000006.12:123547340:TTTTTTT:TTTTTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q22.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="123547341" stop="123547341" display_start="123547341" display_stop="123547341" variantLength="1" positionVCF="123547340" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="123868486" stop="123868486" display_start="123868486" display_stop="123868486" variantLength="1" positionVCF="123868485" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>E142fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.123868492del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.123868492del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.123547347del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.123547347del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_030438.1" sequenceAccession="NG_030438" sequenceVersion="1" change="g.94753del">
            <Expression>NG_030438.1:g.94753del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001251987.2" sequenceAccession="NM_001251987" sequenceVersion="2" change="c.423del">
            <Expression>NM_001251987.2:c.423del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001238916.1" sequenceAccession="NP_001238916" sequenceVersion="1" change="p.Glu142fs">
            <Expression>NP_001238916.1:p.Glu142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256020.2" sequenceAccession="NM_001256020" sequenceVersion="2" change="c.423del">
            <Expression>NM_001256020.2:c.423del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242949.1" sequenceAccession="NP_001242949" sequenceVersion="1" change="p.Glu142fs">
            <Expression>NP_001242949.1:p.Glu142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256021.2" sequenceAccession="NM_001256021" sequenceVersion="2" change="c.423del">
            <Expression>NM_001256021.2:c.423del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242950.1" sequenceAccession="NP_001242950" sequenceVersion="1" change="p.Glu142fs">
            <Expression>NP_001242950.1:p.Glu142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256022.2" sequenceAccession="NM_001256022" sequenceVersion="2" change="c.423del">
            <Expression>NM_001256022.2:c.423del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001242951.1" sequenceAccession="NP_001242951" sequenceVersion="1" change="p.Glu142fs">
            <Expression>NP_001242951.1:p.Glu142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006073.4" sequenceAccession="NM_006073" sequenceVersion="4" change="c.423del" MANESelect="true">
            <Expression>NM_006073.4:c.423del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006064.2" sequenceAccession="NP_006064" sequenceVersion="2" change="p.Glu142fs">
            <Expression>NP_006064.2:p.Glu142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="757805966" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006073.4(TRDN):c.423del (p.Glu142fs) AND Catecholaminergic polymorphic ventricular tachycardia 1" Accession="RCV003104072" Version="11">
        <ClassifiedConditionList TraitSetID="6589">
          <ClassifiedCondition DB="MedGen" ID="C1631597">Catecholaminergic polymorphic ventricular tachycardia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006073.4(TRDN):c.423del (p.Glu142fs) AND Catecholaminergic polymorphic ventricular tachycardia" Accession="RCV004017830" Version="2">
        <ClassifiedConditionList TraitSetID="21630">
          <ClassifiedCondition DB="MedGen" ID="C5574922">Catecholaminergic polymorphic ventricular tachycardia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-30" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-15" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-05-10" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22422768</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25922419</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26200674</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30649896</ID>
        </Citation>
        <DescriptionHistory Dated="2024-04-20">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6589" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4488" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Stress-induced polymorphic ventricular tachycardia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC 1</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Catecholaminergic polymorphic ventricular tachycardia 1</ElementValue>
                <XRef ID="MONDO:0011484" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP1</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CPVT1</ElementValue>
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by episodic syncope occurring during exercise or acute emotion. The underlying cause of these episodes is the onset of fast ventricular tachycardia (bidirectional or polymorphic). Spontaneous recovery may occur when these arrhythmias self-terminate. In other instances, ventricular tachycardia may degenerate into ventricular fibrillation and cause sudden death if cardiopulmonary resuscitation is not readily available. The mean onset of symptoms (usually a syncopal episode) is between age seven and 12 years; onset as late as the fourth decade of life has been reported. If untreated, CPVT is highly lethal, as approximately 30% of affected individuals experience at least one cardiac arrest and up to 80% have one or more syncopal spells. Sudden death may be the first manifestation of the disease.</Attribute>
                <XRef ID="NBK1289" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301466</ID>
                <ID Source="BookShelf">NBK1289</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="3286" DB="Orphanet" />
              <XRef ID="C1631597" DB="MedGen" />
              <XRef ID="MONDO:0011484" DB="MONDO" />
              <XRef Type="MIM" ID="604772" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="21630" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33419" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Catecholaminergic polymorphic ventricular tachycardia</ElementValue>
                <XRef ID="MONDO:0017990" DB="MONDO" />
                <XRef ID="3286" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial polymorphic ventricular tachycardia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Catecholamine-induced polymorphic ventricular tachycardia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polymorphic catecholergic ventricular tachycardia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CVPT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by episodic syncope occurring during exercise or acute emotion. The underlying cause of these episodes is the onset of fast ventricular tachycardia (bidirectional or polymorphic). Spontaneous recovery may occur when these arrhythmias self-terminate. In other instances, ventricular tachycardia may degenerate into ventricular fibrillation and cause sudden death if cardiopulmonary resuscitation is not readily available. The mean onset of symptoms (usually a syncopal episode) is between age seven and 12 years; onset as late as the fourth decade of life has been reported. If untreated, CPVT is highly lethal, as approximately 30% of affected individuals experience at least one cardiac arrest and up to 80% have one or more syncopal spells. Sudden death may be the first manifestation of the disease.</Attribute>
                <XRef ID="NBK1289" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4421" />
                <XRef ID="4421" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301466</ID>
                <ID Source="BookShelf">NBK1289</ID>
              </Citation>
              <XRef ID="3286" DB="Orphanet" />
              <XRef ID="C5574922" DB="MedGen" />
              <XRef ID="MONDO:0017990" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS604772" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3114078" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="992421|MedGen:C1631597" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001588418" DateUpdated="2024-02-20" DateCreated="2021-05-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30649896</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22422768</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25922419</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26200674</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30649896</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1074440). This premature translational stop signal has been observed in individual(s) with clinical features of TRDN-related conditions (PMID: 30649896). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Glu142Lysfs*33) in the TRDN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRDN are known to be pathogenic (PMID: 22422768, 25922419, 26200674, 30649896).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRDN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.123868486del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1631597" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9056319" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="103287251|Orphanet:ORPHA3286" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004848637" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30649896</ID>
          </Citation>
          <Comment>The p.Glu142LysfsX33 variant in TRDN has been reported in homozygous state in 1 individual with TRDN-associated condition (Clemens 2019 PMID: 30649896). It has also been identified in 0.02% (2/11134) of South Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant has also been reported in ClinVar (Variation ID 1074440). This variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at position 142 and leads to a premature termination codon 33 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the TRDN gene is an established disease mechanism in autosomal recessive TRDN-associated catecholaminergic polymorphic ventricular tachycardia (CPVT). In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive CPVT. ACMG/AMP Criteria applied: PVS1, PM3.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRDN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_006073.4:exon 4</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.12:g.123547341delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA3286" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3114078" TraitType="Disease" MappingType="XRef" MappingValue="C1631597" MappingRef="MedGen">
        <MedGen CUI="C1631597" Name="Catecholaminergic polymorphic ventricular tachycardia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9056319" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA3286" MappingRef="Orphanet">
        <MedGen CUI="C5574922" Name="Catecholaminergic polymorphic ventricular tachycardia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

